Development and external validation of a prognostic nomogram for metastatic uveal melanoma.

<h4>Background</h4>Approximately 50% of patients with uveal melanoma (UM) will develop metastatic disease, usually involving the liver. The outcome of metastatic UM (mUM) is generally poor and no standard therapy has been established. Additionally, clinicians lack a validated prognostic...

Full description

Bibliographic Details
Main Authors: Sara Valpione, Justin C Moser, Raffaele Parrozzani, Marco Bazzi, Aaron S Mansfield, Simone Mocellin, Jacopo Pigozzo, Edoardo Midena, Svetomir N Markovic, Camillo Aliberti, Luca G Campana, Vanna Chiarion-Sileni
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0120181